Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4171437

O=C(N[C@@H](CCCSCC(=O)C(F)(F)F)C(=O)NC1CCN(Cc2ccccc2)CC1)c1cccnc1.O=C(O)C(F)(F)F

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.47
DRD4 P21917 2/20 0.43
WNT1 P04628 1/20 0.43
DYRK1A Q13627 1/20 0.43
PRKAB2 O43741 1/20 0.42
PRKAG1 P54619 1/20 0.42
PRKAA2 P54646 1/20 0.42
PRKAA1 Q13131 1/20 0.42
PRKAG3 Q9UGI9 1/20 0.42
PRKAG2 Q9UGJ0 1/20 0.42
PRKAB1 Q9Y478 1/20 0.42
SLC6A5 Q9Y345 1/20 0.42
ACHE P22303 2/20 0.41
LMNA P02545 1/20 0.41
CXCR4 P61073 1/20 0.41
BCHE P06276 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM1 P11229 1/20 0.41
CHRM3 P20309 1/20 0.41
ACKR3 P25106 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4169482 0.86 ALDH1A1 (0.45) SMN1; SMN2
Trifluoroacetic Acid SCHEMBL4606072 0.85 SIGMAR1 (0.52) SIGMAR1
Trifluoroacetic Acid SCHEMBL4159826 0.84 CCR2 (0.49) SIGMAR1ACHEBCHE
Trifluoroacetic Acid SCHEMBL4164045 0.82 TSHR (0.44) SIGMAR1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL4154002 0.81 CYP2C19 (0.48) SIGMAR1DRD4SMN1; SMN2
Trifluoroacetic Acid SCHEMBL4165152 0.81 ALDH1A1 (0.39) LMNA
Trifluoroacetic Acid SCHEMBL4161039 0.80 SIGMAR1 (0.57) SIGMAR1DRD4CHRM2CHRM1CHRM3
SCHEMBL4174326 0.79 KMT2A (0.52) LMNAMAPTSMN1; SMN2
SCHEMBL5127760 0.79 SIGMAR1 (0.51) SIGMAR1DRD4WNT1DYRK1APRKAB2
Trifluoroacetic Acid SCHEMBL4157968 0.79 PADI4 (0.49) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 SIGMAR1 3623/4885DRD4 2685/4885WNT1 2681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.